The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N4-(2-(1H-indol-3-yl)ethyl)-6-fluoro-N2-(1H-indazol-5-yl)quinazoline-2,4-diamine ID: ALA4095923
PubChem CID: 137653619
Max Phase: Preclinical
Molecular Formula: C25H20FN7
Molecular Weight: 437.48
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: Fc1ccc2nc(NCCc3c[nH]c4ccccc34)nc(Nc3ccc4[nH]ncc4c3)c2c1
Standard InChI: InChI=1S/C25H20FN7/c26-17-5-7-23-20(12-17)24(30-18-6-8-21-16(11-18)14-29-33-21)32-25(31-23)27-10-9-15-13-28-22-4-2-1-3-19(15)22/h1-8,11-14,28H,9-10H2,(H,29,33)(H2,27,30,31,32)
Standard InChI Key: FITNDRQKVSRYMN-UHFFFAOYSA-N
Molfile:
RDKit 2D
33 38 0 0 0 0 0 0 0 0999 V2000
29.9870 -4.4656 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.9859 -5.2852 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.6939 -5.6941 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.6921 -4.0568 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.4008 -4.4620 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.4015 -5.2810 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.1101 -5.6881 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.8183 -5.2773 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.8136 -4.4552 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.1045 -4.0518 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.6897 -3.2396 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.2779 -5.6932 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.3962 -2.8289 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.1030 -3.2377 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.8090 -2.8277 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.3900 -2.0157 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.0931 -1.6033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.8032 -2.0079 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.4074 -1.4576 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.0707 -0.7129 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.2585 -0.8030 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5705 -5.2840 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.8624 -5.6921 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.1550 -5.2829 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.8616 -5.0048 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.4080 -5.6124 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.2708 -4.2973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.0656 -4.4690 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.6098 -3.8672 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.3602 -3.0935 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.5615 -2.9250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.0208 -3.5282 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.5188 -4.0423 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
4 11 1 0
2 12 1 0
11 13 1 0
13 14 2 0
14 15 1 0
15 18 2 0
17 16 2 0
16 13 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 21 2 0
21 17 1 0
12 22 1 0
22 23 1 0
23 24 1 0
24 28 1 0
27 25 1 0
25 26 1 0
26 24 2 0
27 28 2 0
28 29 1 0
29 30 2 0
30 31 1 0
31 32 2 0
32 27 1 0
9 33 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 437.48Molecular Weight (Monoisotopic): 437.1764AlogP: 5.52#Rotatable Bonds: 6Polar Surface Area: 94.31Molecular Species: NEUTRALHBA: 5HBD: 4#RO5 Violations: 1HBA (Lipinski): 7HBD (Lipinski): 4#RO5 Violations (Lipinski): 1CX Acidic pKa: 13.08CX Basic pKa: 4.94CX LogP: 5.19CX LogD: 5.19Aromatic Rings: 6Heavy Atoms: 33QED Weighted: 0.28Np Likeness Score: -1.61
References 1. Hao C, Huang W, Li X, Guo J, Chen M, Yan Z, Wang K, Jiang X, Song S, Wang J, Zhao D, Li F, Cheng M.. (2017) Development of 2, 4-diaminoquinazoline derivatives as potent PAK4 inhibitors by the core refinement strategy., 131 [PMID:28284095 ] [10.1016/j.ejmech.2017.02.063 ]